|
1
|
Bartlett DL, Fong Y, Fortner JG, Brennan
MF and Blumgart LH: Long-term results after resection for
gallbladder cancer. Implications for staging and management. Ann
Surg. 224:639–646. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cubertafond P, Gainant A and Cucchiaro G:
Surgical treatment of 724 carcinomas of the gallbladder. Results of
the French surgical association survey. Ann Surg. 219:275–280.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Randi G, Malvezzi M, Levi F, Ferlay J,
Negri E, Franceschi S and La Vecchia C: Epidemiology of biliary
tract cancers: An update. Ann Oncol. 20:146–159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shukla VK, Chauhan VS, Mishra RN and Basu
S: Lifestyle, reproductive factors and risk of gallbladder cancer.
Singapore Med J. 49:912–915. 2008.PubMed/NCBI
|
|
5
|
Miller G and Jarnagin WR: Gallbladder
carcinoma. Eur J Surg Oncol. 34:306–312. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu G, Chen X, Wang X, Li X, Du Q, Hong H,
Tang N, She F and Chen Y: Expression of the RIP-1 gene and its role
in growth and invasion of human gallbladder carcinoma. Cell Physiol
Biochem. 34:1152–1165. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park S, Hatanpaa KJ, Xie Y, Mickey BE,
Madden CJ, Raisanen JM, Ramnarain DB, Xiao G, Saha D, Boothman DA,
et al: The receptor interacting protein 1 inhibits p53 induction
through NF-kappaB activation and confers a worse prognosis in
glioblastoma. Cancer Res. 69:2809–2816. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hsu H, Huang J, Shu HB, Baichwal V and
Goeddel DV: TNF-dependent recruitment of the protein kinase RIP to
the TNF receptor-1 signaling complex. Immunity. 4:387–396. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kelliher MA, Grimm S, Ishida Y, Kuo F,
Stanger BZ and Leder P: The death domain kinase RIP mediates the
TNF-induced NF-kappaB signal. Immunity. 8:297–303. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hur GM, Lewis J, Yang Q, Lin Y, Nakano H,
Nedospasov S and Liu ZG: The death domain kinase RIP has an
essential role in DNA damage-induced NF-kappa B activation. Genes
Dev. 17:873–882. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Devin A, Lin Y and Liu ZG: The role of the
death-domain kinase RIP in tumour-necrosis-factor-induced
activation of mitogen-activated protein kinases. EMBO Rep.
4:623–627. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu ZG, Hsu H, Goeddel DV and Karin M:
Dissection of TNF receptor 1 effector functions: JNK activation is
not linked to apoptosis while NF-kappaB activation prevents cell
death. Cell. 87:565–576. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pacifico F and Leonardi A: NF-kappaB in
solid tumors. Biochem Pharmacol. 72:1142–1152. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu G, Du Q, Wang X, Tang N, She F and
Chen Y: TNF-α promotes gallbladder cancer cell growth and invasion
through autocrine mechanisms. Int J Mol Med. 33:1431–1440. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Horiuchi H, Kawamata H, Fujimori T and
Kuroda Y: A MEK inhibitor (U0126) prolongs survival in nude mice
bearing human gallbladder cancer cells with K-ras mutation:
Analysis in a novel orthotopic inoculation model. Int J Oncol.
23:957–963. 2003.PubMed/NCBI
|
|
16
|
Du Q, Jiang L, Wang XQ, Pan W, She FF and
Chen YL: Establishment of and comparison between orthotopic
xenograft and subcutaneous xenograft models of gallbladder
carcinoma. Asian Pac J Cancer Prev. 15:3747–3752. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Homma S, Hasumura S, Nagamori S and Kameda
H: Establishment and characterization of a human gall bladder
carcinoma cell line NOZ. Hum Cell. 1:95–97. 1988.PubMed/NCBI
|
|
18
|
Heckman KL and Pease LR: Gene splicing and
mutagenesis by PCR-driven overlap extension. Nat Protoc. 2:924–932.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rettino A, Rafanelli F, Genovese G,
Goracci M, Cifarelli RA, Cittadini A and Sgambato A: Identification
of Sp1 and GC-boxes as transcriptional regulators of mouse Dag1
gene promoter. Am J Physiol Cell Physiol. 297:C1113–C1123. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu YL, Peng XE, Wang D, Chen WN and Lin X:
Human liver fatty acid binding protein (hFABP1) gene is regulated
by liver-enriched transcription factors HNF3β and C/EBPα.
Biochimie. 94:384–392. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ceelie H, Spaargaren-Van Riel CC, De Jong
M, Bertina RM and Vos HL: Functional characterization of
transcription factor binding sites for HNF1-alpha, HNF3-beta
(FOXA2), HNF4-alpha, Sp1 and Sp3 in the human prothrombin gene
enhancer. J Thromb Haemost. 1:1688–1698. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Weidner N, Semple JP, Welch WR and Folkman
J: Tumor angiogenesis and metastasis-correlation in invasive breast
carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vermeulen PB, Gasparini G, Fox SB, Toi M,
Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL
and Dirix LY: Quantification of angiogenesis in solid human
tumours: An international consensus on the methodology and criteria
of evaluation. Eur J Cancer. 32A:2474–2484. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Du Q, Jiang L, Wang X, Wang M, She F and
Chen Y: Tumor necrosis factor-α promotes the lymphangiogenesis of
gallbladder carcinoma through nuclear factor-κB-mediated
upregulation of vascular endothelial growth factor-C. Cancer Sci.
105:1261–1271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
O'Donnell MA and Ting AT: RIP1 comes back
to life as a cell death regulator in TNFR1 signaling. FEBS J.
278:877–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hitomi J, Christofferson DE, Ng A, Yao J,
Degterev A, Xavier RJ and Yuan J: Identification of a molecular
signaling network that regulates a cellular necrotic cell death
pathway. Cell. 135:1311–1323. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ting AT, Pimentel-Muiños FX and Seed B:
RIP mediates tumor necrosis factor receptor 1 activation of
NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J.
15:6189–6196. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Devin A, Lin Y, Yamaoka S, Li Z, Karin M
and Liu Z: The alpha and beta subunits of IkappaB kinase (IKK)
mediate TRAF2-dependent IKK recruitment to tumor necrosis factor
(TNF) receptor 1 in response to TNF. Mol Cell Biol. 21:3986–3994.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Han W, Xie J, Fang Y, Wang Z and Pan H:
Nec-1 enhances shikonin-induced apoptosis in leukemia cells by
inhibition of RIP-1 and ERK1/2. Int J Mol Sci. 13:7212–7225. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Azijli K, Yuvaraj S, Peppelenbosch MP,
Würdinger T, Dekker H, Joore J, van Dijk E, Quax WJ, Peters GJ, de
Jong S and Kruyt FA: Kinome profiling of non-canonical TRAIL
signaling reveals RIP1-Src-STAT3-dependent invasion in resistant
non-small cell lung cancer cells. J Cell Sci. 125:4651–4661. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jüttner S, Wissmann C, Jöns T, Vieth M,
Hertel J, Gretschel S, Schlag PM, Kemmner W and Höcker M: Vascular
endothelial growth factor-D and its receptor VEGFR-3: Two novel
independent prognostic markers in gastric adenocarcinoma. J Clin
Oncol. 24:228–240. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Arinaga M, Noguchi T, Takeno S, Chujo M,
Miura T and Uchida Y: Clinical significance of vascular endothelial
growth factor C and vascular endothelial growth factor receptor 3
in patients with nonsmall cell lung carcinoma. Cancer. 97:457–464.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Achen MG, McColl BK and Stacker SA: Focus
on lymphangiogenesis in tumor metastasis. Cancer Cell. 7:121–127.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Timoshenko AV, Rastogi S and Lala PK:
Migration-promoting role of VEGF-C and VEGF-C binding receptors in
human breast cancer cells. Br J Cancer. 97:1090–1098. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Masood R, Kundra A, Zhu S, Xia G, Scalia
P, Smith DL and Gill PS: Malignant mesothelioma growth inhibition
by agents that target the VEGF and VEGF-C autocrine loops. Int J
Cancer. 104:603–610. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shimada H, Endo I, Togo S, Nakano A, Izumi
T and Nakagawara G: The role of lymph node dissection in the
treatment of gallbladder carcinoma. Cancer. 79:892–899. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen Y, Jiang L, She F, Tang N, Wang X, Li
X, Han S and Zhu J: Vascular endothelial growth factor-C promotes
the growth and invasion of gallbladder cancer via an autocrine
mechanism. Mol Cell Biochem. 345:77–89. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ernst P and Smale ST: Combinatorial
regulation of transcription. I: General aspects of transcriptional
control. Immunity. 2:311–319. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fidler IJ: Critical factors in the biology
of human cancer metastasis: Twenty-eighth G.H.A. Clowes memorial
award lecture. Cancer Res. 50:6130–6138. 1990.PubMed/NCBI
|
